首页> 外文期刊>Pediatric blood & cancer >Preventing Infections in Sickle Cell Disease: The Unfinished Business
【24h】

Preventing Infections in Sickle Cell Disease: The Unfinished Business

机译:预防镰状细胞病感染:未完成的业务

获取原文
获取原文并翻译 | 示例
           

摘要

While encapsulated bacterial agents, particularly Streptococcus pneumoniae, are recognized as important microbes that are associated with serious illness in hosts with sickle cell disease (SCD), multiple pathogens are implicated in infectious manifestations of SCD. Variations in clinical practice have been an obstacle to the universal implementation of infection preventive management through active, targeted vaccination of these individuals and routine usage of antibiotic prophylaxis. Paradoxically, in low-income settings, there is evidence that SCD also increases the risk for several other infections that warrant additional infection preventive measures. The infection preventive care among patients with SCD in developed countries does not easily translate to the adoption of these recommendations globally, which must take into account the local epidemiology of infections, available vaccines and population-specific vaccine efficacy, environment, health care behaviors, and cultural beliefs, as these are all factors that play a complex role in the manifestation of SCD and the prevention of infectious disease morbidity.
机译:尽管封装的细菌剂,特别是肺炎链球菌被认为是与镰状细胞病(SCD)宿主严重疾病相关的重要微生物,但多种病原体与SCD的感染性表现有关。通过对这些人进行有针对性的主动疫苗接种和常规使用抗生素预防措施,临床实践中的差异已成为普遍实施感染预防管理的障碍。矛盾的是,在低收入环境中,有证据表明,SCD还增加了其他几种感染的风险,需要采取其他预防措施。在发达国家,患有SCD的患者的预防感染护理并不容易转化为在全球范围内采纳这些建议,这些建议必须考虑到当地的感染流行病学,可用的疫苗和特定人群的疫苗功效,环境,卫生保健行为以及文化信仰,因为这些都是在SCD的表现和预防传染病发病率中起复杂作用的因素。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号